CN105944070A - Medicine preparation for treating intensive care respiratory system infection and preparation method thereof - Google Patents
Medicine preparation for treating intensive care respiratory system infection and preparation method thereof Download PDFInfo
- Publication number
- CN105944070A CN105944070A CN201610521125.8A CN201610521125A CN105944070A CN 105944070 A CN105944070 A CN 105944070A CN 201610521125 A CN201610521125 A CN 201610521125A CN 105944070 A CN105944070 A CN 105944070A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- powder
- rhizoma
- rhizoma zingiberis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002345 respiratory system Anatomy 0.000 title claims abstract description 26
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title abstract description 20
- 239000003814 drug Substances 0.000 title abstract description 17
- 229940079593 drug Drugs 0.000 title description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 27
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 8
- 235000008397 ginger Nutrition 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 30
- 238000002560 therapeutic procedure Methods 0.000 claims description 21
- 244000025254 Cannabis sativa Species 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 7
- 239000000571 coke Substances 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 3
- 241000234314 Zingiber Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 244000273928 Zingiber officinale Species 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 5
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 abstract 1
- 235000015763 Artemisia ludoviciana Nutrition 0.000 abstract 1
- 241000608847 Gnaphalium Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 22
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 21
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- -1 terpene lactones Chemical class 0.000 description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 15
- 208000026435 phlegm Diseases 0.000 description 15
- 239000000341 volatile oil Substances 0.000 description 15
- 241000700159 Rattus Species 0.000 description 14
- 229930182470 glycoside Natural products 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 150000002338 glycosides Chemical class 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 150000001336 alkenes Chemical class 0.000 description 7
- 230000000954 anitussive effect Effects 0.000 description 7
- 229930006722 beta-pinene Natural products 0.000 description 7
- 239000003172 expectorant agent Substances 0.000 description 7
- 230000003419 expectorant effect Effects 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 235000021251 pulses Nutrition 0.000 description 7
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 7
- UJBOOUHRTQVGRU-UHFFFAOYSA-N 3-methylcyclohexan-1-one Chemical compound CC1CCCC(=O)C1 UJBOOUHRTQVGRU-UHFFFAOYSA-N 0.000 description 6
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 6
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 6
- 150000004702 methyl esters Chemical class 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 6
- 229930187070 Decuroside Natural products 0.000 description 5
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 5
- 206010036790 Productive cough Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- NDVASEGYNIMXJL-UHFFFAOYSA-N beta-sabinene Natural products C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 235000001510 limonene Nutrition 0.000 description 5
- 229940087305 limonene Drugs 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 4
- YRAQEMCYCSSHJG-NSHDSACASA-N (S)-columbianetin Chemical compound C1=CC(=O)OC2=C1C=CC1=C2C[C@@H](C(C)(O)C)O1 YRAQEMCYCSSHJG-NSHDSACASA-N 0.000 description 4
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 4
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 4
- 208000008017 Hypohidrosis Diseases 0.000 description 4
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 4
- 206010057190 Respiratory tract infections Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 125000005594 diketone group Chemical group 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 4
- VSMOENVRRABVKN-UHFFFAOYSA-N oct-1-en-3-ol Chemical compound CCCCCC(O)C=C VSMOENVRRABVKN-UHFFFAOYSA-N 0.000 description 4
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 4
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 4
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 4
- 210000003800 pharynx Anatomy 0.000 description 4
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 4
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 4
- KQAZVFVOEIRWHN-UHFFFAOYSA-N α-thujene Chemical compound CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 4
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 3
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 3
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 3
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 3
- FAMPSKZZVDUYOS-UHFFFAOYSA-N 2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 3
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000712431 Influenza A virus Species 0.000 description 3
- AOAFVSVYRSUDBN-UHFFFAOYSA-N Methyl-14-methylhexadecanoat Natural products CCC(C)CCCCCCCCCCCCC(=O)OC AOAFVSVYRSUDBN-UHFFFAOYSA-N 0.000 description 3
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 229960002045 bergapten Drugs 0.000 description 3
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- FXHGMKSSBGDXIY-UHFFFAOYSA-N heptanal Chemical compound CCCCCCC=O FXHGMKSSBGDXIY-UHFFFAOYSA-N 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229930007503 menthone Natural products 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- HTSABYAWKQAHBT-UHFFFAOYSA-N trans 3-methylcyclohexanol Natural products CC1CCCC(O)C1 HTSABYAWKQAHBT-UHFFFAOYSA-N 0.000 description 3
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 2
- LFJQCDVYDGGFCH-JTQLQIEISA-N (+)-β-phellandrene Chemical compound CC(C)[C@@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-JTQLQIEISA-N 0.000 description 2
- LFJQCDVYDGGFCH-SNVBAGLBSA-N (+/-)-beta-Phellandrene Natural products CC(C)[C@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-SNVBAGLBSA-N 0.000 description 2
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- 239000001306 (7E,9E,11E,13E)-pentadeca-7,9,11,13-tetraen-1-ol Substances 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- JSNRRGGBADWTMC-QINSGFPZSA-N (E)-beta-Farnesene Natural products CC(C)=CCC\C(C)=C/CCC(=C)C=C JSNRRGGBADWTMC-QINSGFPZSA-N 0.000 description 2
- IHPKGUQCSIINRJ-CSKARUKUSA-N (E)-beta-ocimene Chemical compound CC(C)=CC\C=C(/C)C=C IHPKGUQCSIINRJ-CSKARUKUSA-N 0.000 description 2
- HDNGHNOEMOMCKM-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)decane-3,5-diol Chemical compound CCCCCC(O)CC(O)CCC1=CC=C(OC)C(OC)=C1 HDNGHNOEMOMCKM-UHFFFAOYSA-N 0.000 description 2
- VSMOENVRRABVKN-MRVPVSSYSA-N 1-Octen-3-ol Natural products CCCCC[C@H](O)C=C VSMOENVRRABVKN-MRVPVSSYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- IAIHUHQCLTYTSF-UHFFFAOYSA-N 2,2,4-trimethylbicyclo[2.2.1]heptan-3-ol Chemical compound C1CC2(C)C(O)C(C)(C)C1C2 IAIHUHQCLTYTSF-UHFFFAOYSA-N 0.000 description 2
- RPPLFPVIBFQGJC-UHFFFAOYSA-N 3,7,7-trimethylbicyclo[4.1.0]heptan-2-ol Chemical compound OC1C(C)CCC2C(C)(C)C12 RPPLFPVIBFQGJC-UHFFFAOYSA-N 0.000 description 2
- YSTPAHQEHQSRJD-UHFFFAOYSA-N 3-Carvomenthenone Chemical compound CC(C)C1CCC(C)=CC1=O YSTPAHQEHQSRJD-UHFFFAOYSA-N 0.000 description 2
- YDXQPTHHAPCTPP-UHFFFAOYSA-N 3-Octen-1-ol Natural products CCCCC=CCCO YDXQPTHHAPCTPP-UHFFFAOYSA-N 0.000 description 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 2
- NZXWDTCLMXDSHY-UHFFFAOYSA-N 5,5,6-trimethyl-2,3,4,7-tetrahydro-1h-tricyclo[2.2.1.0^{2,6}]heptane Chemical compound C1C2C3(C)C2C(C)(C)C1C3 NZXWDTCLMXDSHY-UHFFFAOYSA-N 0.000 description 2
- KFGNBHYXXGAQKA-UHFFFAOYSA-N 6-gingerdiol Natural products CCCCCC(O)CC(O)CCc1ccc(OC)c(O)c1 KFGNBHYXXGAQKA-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QQRSPHJOOXUALR-UHFFFAOYSA-N Apiole Chemical compound COC1=CC(CC=C)=C(OC)C2=C1OCO2 QQRSPHJOOXUALR-UHFFFAOYSA-N 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 2
- 235000010591 Appio Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241001478240 Coccus Species 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- QAGGICSUEVNSGH-UHFFFAOYSA-N Diosmetin Natural products C1=C(O)C(OC)=CC=C1C1=CC(=O)C2=CC=C(O)C=C2O1 QAGGICSUEVNSGH-UHFFFAOYSA-N 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 239000009517 FM 100 Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000134874 Geraniales Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 206010018691 Granuloma Diseases 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- RMIANEGNSBUGDJ-UHFFFAOYSA-N Isopulegone Chemical compound CC1CCC(C(C)=C)C(=O)C1 RMIANEGNSBUGDJ-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- YRAQEMCYCSSHJG-UHFFFAOYSA-N Tetrahydro-oroselol Natural products C1=CC(=O)OC2=C1C=CC1=C2CC(C(C)(O)C)O1 YRAQEMCYCSSHJG-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- DTUNXJRSMOTKGD-UHFFFAOYSA-N [1-(4-hydroxy-3-methoxyphenyl)-3-oxodecan-5-yl] acetate Chemical compound CCCCCC(OC(C)=O)CC(=O)CCC1=CC=C(O)C(OC)=C1 DTUNXJRSMOTKGD-UHFFFAOYSA-N 0.000 description 2
- KMNVXQHNIWUUSE-UHFFFAOYSA-N [6]-Gingerdione Chemical compound CCCCCC(=O)CC(=O)CCC1=CC=C(O)C(OC)=C1 KMNVXQHNIWUUSE-UHFFFAOYSA-N 0.000 description 2
- 229930016183 alpha-curcumene Natural products 0.000 description 2
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 2
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- DBMJZOMNXBSRED-OQLLNIDSSA-N bergomottin Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC/C=C(C)/CCC=C(C)C DBMJZOMNXBSRED-OQLLNIDSSA-N 0.000 description 2
- OJYKYCDSGQGTRJ-INLOORNJSA-N beta-Santalol Natural products C1C[C@H]2C(=C)[C@](CC\C=C(CO)/C)(C)[C@@H]1C2 OJYKYCDSGQGTRJ-INLOORNJSA-N 0.000 description 2
- YSNRTFFURISHOU-UHFFFAOYSA-N beta-farnesene Natural products C=CC(C)CCC=C(C)CCC=C(C)C YSNRTFFURISHOU-UHFFFAOYSA-N 0.000 description 2
- LFJQCDVYDGGFCH-UHFFFAOYSA-N beta-phellandrene Natural products CC(C)C1CCC(=C)C=C1 LFJQCDVYDGGFCH-UHFFFAOYSA-N 0.000 description 2
- OJYKYCDSGQGTRJ-GQYWAMEOSA-N beta-santalol Chemical compound C1C[C@H]2C(=C)[C@@](CC/C=C(CO)/C)(C)[C@@H]1C2 OJYKYCDSGQGTRJ-GQYWAMEOSA-N 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 229930006739 camphene Natural products 0.000 description 2
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 2
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- WTEVQBCEXWBHNA-YFHOEESVSA-N citral B Natural products CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- DQISGWRLCDLKJI-UHFFFAOYSA-N columbianetin Natural products C1=CC(=O)OC2=C(C(C(C(C)(O)C)O3)O)C3=CC=C21 DQISGWRLCDLKJI-UHFFFAOYSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000011443 conventional therapy Methods 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- AZOCECCLWFDTAP-UHFFFAOYSA-N dihydrocarvone Chemical compound CC1CCC(C(C)=C)CC1=O AZOCECCLWFDTAP-UHFFFAOYSA-N 0.000 description 2
- 235000015428 diosmetin Nutrition 0.000 description 2
- MBNGWHIJMBWFHU-UHFFFAOYSA-N diosmetin Chemical compound C1=C(O)C(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 MBNGWHIJMBWFHU-UHFFFAOYSA-N 0.000 description 2
- 229960001876 diosmetin Drugs 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 150000002561 ketenes Chemical class 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- BJIUDNXPLSJWKE-UHFFFAOYSA-N methyl 12-methyltetradecanoate Natural products CCC(C)CCCCCCCCCCC(=O)OC BJIUDNXPLSJWKE-UHFFFAOYSA-N 0.000 description 2
- QGBRLVONZXHAKJ-UHFFFAOYSA-N methyl arachidate Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)OC QGBRLVONZXHAKJ-UHFFFAOYSA-N 0.000 description 2
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- NMRPBPVERJPACX-UHFFFAOYSA-N octan-3-ol Chemical compound CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- YKNWIILGEFFOPE-UHFFFAOYSA-N pentacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCC YKNWIILGEFFOPE-UHFFFAOYSA-N 0.000 description 2
- HKZQJZIFODOLFR-UHFFFAOYSA-N piperitenone Chemical compound CC(C)=C1CCC(C)=CC1=O HKZQJZIFODOLFR-UHFFFAOYSA-N 0.000 description 2
- 229930006968 piperitone Natural products 0.000 description 2
- 229930194443 polygalin Natural products 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 239000002510 pyrogen Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 229930006696 sabinene Natural products 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- CXENHBSYCFFKJS-UHFFFAOYSA-N α-farnesene Chemical compound CC(C)=CCCC(C)=CCC=C(C)C=C CXENHBSYCFFKJS-UHFFFAOYSA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- YOVSPTNQHMDJAG-QLFBSQMISA-N β-eudesmene Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(=C)C)CC[C@]21C YOVSPTNQHMDJAG-QLFBSQMISA-N 0.000 description 2
- IHPKGUQCSIINRJ-UHFFFAOYSA-N β-ocimene Natural products CC(C)=CCC=C(C)C=C IHPKGUQCSIINRJ-UHFFFAOYSA-N 0.000 description 2
- YGWFATZZDWWLRC-UHFFFAOYSA-N (+)-Marmesin Natural products O1C(=O)C=CC2=C1C=C1OCC(C(C)(O)C)C1=C2 YGWFATZZDWWLRC-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- FWYSBEAFFPBAQU-LBPRGKRZSA-N (+)-marmesin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@@H](C(C)(O)C)OC1=C2 FWYSBEAFFPBAQU-LBPRGKRZSA-N 0.000 description 1
- NFLGAXVYCFJBMK-DTWKUNHWSA-N (+)-menthone Chemical compound CC(C)[C@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-DTWKUNHWSA-N 0.000 description 1
- XZRVRYFILCSYSP-OAHLLOKOSA-N (-)-beta-bisabolene Chemical compound CC(C)=CCCC(=C)[C@H]1CCC(C)=CC1 XZRVRYFILCSYSP-OAHLLOKOSA-N 0.000 description 1
- 229930006727 (-)-endo-fenchol Natural products 0.000 description 1
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- KUNFMZSTKSLIEY-GRHHLOCNSA-N (2s)-2-azanyl-3-phenyl-propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=CC=C1 KUNFMZSTKSLIEY-GRHHLOCNSA-N 0.000 description 1
- HOZBSSWDEKVXNO-BXRBKJIMSA-N (2s)-2-azanylbutanedioic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CC(O)=O HOZBSSWDEKVXNO-BXRBKJIMSA-N 0.000 description 1
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- DCSCXTJOXBUFGB-JGVFFNPUSA-N (R)-(+)-Verbenone Natural products CC1=CC(=O)[C@@H]2C(C)(C)[C@H]1C2 DCSCXTJOXBUFGB-JGVFFNPUSA-N 0.000 description 1
- WUOACPNHFRMFPN-VIFPVBQESA-N (R)-(+)-alpha-terpineol Chemical compound CC1=CC[C@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-VIFPVBQESA-N 0.000 description 1
- DCSCXTJOXBUFGB-SFYZADRCSA-N (R)-(+)-verbenone Chemical compound CC1=CC(=O)[C@H]2C(C)(C)[C@@H]1C2 DCSCXTJOXBUFGB-SFYZADRCSA-N 0.000 description 1
- VVFXXDIPJNSMPW-UHFFFAOYSA-N 1,1,4a-trimethyl-7-propan-2-yl-2,3,4,4b,5,6,8a,10a-octahydrophenanthrene Chemical compound C1=CC2C(C)(C)CCCC2(C)C2C1C=C(C(C)C)CC2 VVFXXDIPJNSMPW-UHFFFAOYSA-N 0.000 description 1
- 150000000193 1,8-cineol derivatives Chemical class 0.000 description 1
- VDMXPMYSWFDBJB-UHFFFAOYSA-N 1-ethoxypentane Chemical compound CCCCCOCC VDMXPMYSWFDBJB-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- JXBSHSBNOVLGHF-UHFFFAOYSA-N 10-cis-Dihydrofarnesen Natural products CC=C(C)CCC=C(C)CCC=C(C)C JXBSHSBNOVLGHF-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- CZQNYPBIOHVQQN-CSKARUKUSA-N 2-phenylethyl (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)OCCC=2C=CC=CC=2)=C1 CZQNYPBIOHVQQN-CSKARUKUSA-N 0.000 description 1
- NOQKKFBBAODEHN-UHFFFAOYSA-N 3,5-dimethylcyclohex-2-en-1-one Chemical compound CC1CC(C)=CC(=O)C1 NOQKKFBBAODEHN-UHFFFAOYSA-N 0.000 description 1
- OSUJYLRDFDGEHZ-UHFFFAOYSA-N 3,7-dimethylocta-1,3,6-triene Chemical compound CC(C)=CCC=C(C)C=C.CC(C)=CCC=C(C)C=C OSUJYLRDFDGEHZ-UHFFFAOYSA-N 0.000 description 1
- NMRPBPVERJPACX-QMMMGPOBSA-N 3-Octanol Natural products CCCCC[C@@H](O)CC NMRPBPVERJPACX-QMMMGPOBSA-N 0.000 description 1
- AOKRXIIIYJGNNU-UHFFFAOYSA-N 3-methylcyclopentan-1-one Chemical compound CC1CCC(=O)C1 AOKRXIIIYJGNNU-UHFFFAOYSA-N 0.000 description 1
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 1
- QCJKXQWAFFZFLJ-UHFFFAOYSA-N 6-Methylgingediacetate Natural products CCCCCC(OC(C)=O)CC(OC(C)=O)CCC1=CC=C(OC)C(OC)=C1 QCJKXQWAFFZFLJ-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 1
- NVZULJTUMCKVQR-UHFFFAOYSA-N C1C(C)=CCC2C(C)(C)C12.C1C(C)=CCC2C(C)(C)C12 Chemical compound C1C(C)=CCC2C(C)(C)C12.C1C(C)=CCC2C(C)(C)C12 NVZULJTUMCKVQR-UHFFFAOYSA-N 0.000 description 1
- WCEASIFXIDFWHE-JPAZAREGSA-N Cammaconine Chemical compound O[C@@H]1[C@H]2[C@@H]3[C@@]4([C@@H]5C6)[C@@H](OC)CC[C@@]5(CO)CN(CC)C4[C@H]6[C@@]2(O)C[C@H](OC)[C@H]1C3 WCEASIFXIDFWHE-JPAZAREGSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 241001147468 Chondrus ocellatus Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- VLXDPFLIRFYIME-GZBLMMOJSA-N Copaene Natural products C1C=C(C)[C@H]2[C@]3(C)CC[C@H](C(C)C)[C@H]2[C@@H]31 VLXDPFLIRFYIME-GZBLMMOJSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 229930187095 Deapio-platycodin Natural products 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- OPQCAZJRIRHZQK-UHFFFAOYSA-N Eucarvone Natural products CC1=CC=CCC(C)(C)C1=O OPQCAZJRIRHZQK-UHFFFAOYSA-N 0.000 description 1
- QNGQIURXCUHNAT-UHFFFAOYSA-N Eucarvone Chemical compound CC1=CC=CC(C)(C)CC1=O QNGQIURXCUHNAT-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000008265 Favism Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- MBPTXJNHCBXMBP-PWSCQACJSA-N Galanolactone Natural products O=C1/C(=C\C[C@@H]2[C@@]3(C)[C@H](C(C)(C)CCC3)CC[C@@]32OC3)/CCO1 MBPTXJNHCBXMBP-PWSCQACJSA-N 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018444 Glucose-6-phosphate dehydrogenase deficiency Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- TWVJWDMOZJXUID-SDDRHHMPSA-N Guaiol Chemical compound C1([C@H](CC[C@H](C2)C(C)(C)O)C)=C2[C@@H](C)CC1 TWVJWDMOZJXUID-SDDRHHMPSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- VUVUIDMZOWHIIJ-UHFFFAOYSA-N Methyl-n-nonadecyl-keton Natural products CCCCCCCCCCCCCCCCCCCC(C)=O VUVUIDMZOWHIIJ-UHFFFAOYSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- FMCGSUUBYTWNDP-UHFFFAOYSA-N N-Methylephedrine Natural products CN(C)C(C)C(O)C1=CC=CC=C1 FMCGSUUBYTWNDP-UHFFFAOYSA-N 0.000 description 1
- 206010029379 Neutrophilia Diseases 0.000 description 1
- HXCGUCZXPFBNRD-DNLMCPORSA-N Nodakenin Chemical compound CC(C)([C@@H]1OC2=CC=3OC(=O)C=CC=3C=C2C1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HXCGUCZXPFBNRD-DNLMCPORSA-N 0.000 description 1
- HXCGUCZXPFBNRD-QVYYAULWSA-N Nodakenin Natural products O(C(C)(C)[C@@H]1Oc2c(cc3c(OC(=O)C=C3)c2)C1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HXCGUCZXPFBNRD-QVYYAULWSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 1
- SNBPZAIQWQXUCR-UHFFFAOYSA-N Schizonol Natural products CC1CC=C(C(C)(C)O)C(=O)C1 SNBPZAIQWQXUCR-UHFFFAOYSA-N 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- PBWOIPCULUXTNY-UHFFFAOYSA-N Sitosterylacetat Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 PBWOIPCULUXTNY-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- HRBMESHSNKKVBJ-OLKYXYMISA-N [(1r,4r,5r,7s)-8-benzyl-7-[[4-(dimethylamino)phenyl]carbamoyl]-8-azabicyclo[3.2.1]octan-4-yl] n-ethylcarbamate Chemical compound N1([C@@H]2C[C@@H]([C@H]1CC[C@H]2OC(=O)NCC)C(=O)NC=1C=CC(=CC=1)N(C)C)CC1=CC=CC=C1 HRBMESHSNKKVBJ-OLKYXYMISA-N 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- HWRUWGGHONNRDT-ZOWGANQTSA-N [C@H]1(CC=C(C)C=C1)[C@H](C)CCC=C(C)C.[C@H]1(CC=C(C)C=C1)[C@H](C)CCC=C(C)C Chemical compound [C@H]1(CC=C(C)C=C1)[C@H](C)CCC=C(C)C.[C@H]1(CC=C(C)C=C1)[C@H](C)CCC=C(C)C HWRUWGGHONNRDT-ZOWGANQTSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- YMBFCQPIMVLNIU-KKUMJFAQSA-N alpha-Bergamotene Natural products C1[C@@H]2[C@](CCC=C(C)C)(C)[C@H]1CC=C2C YMBFCQPIMVLNIU-KKUMJFAQSA-N 0.000 description 1
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 1
- PFXFABJPDNHACA-UHFFFAOYSA-N alpha-copaene Natural products CC(C)C1C2CC(=CCC2C3(C)CC13)C PFXFABJPDNHACA-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- OZQAPQSEYFAMCY-UHFFFAOYSA-N alpha-selinene Natural products C1CC=C(C)C2CC(C(=C)C)CCC21C OZQAPQSEYFAMCY-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- GZASGKSFGDNCJI-UHFFFAOYSA-N benzyl benzoate;2-benzylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1CC1=CC=CC=C1.C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 GZASGKSFGDNCJI-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- XZRVRYFILCSYSP-UHFFFAOYSA-N beta-Bisabolene Natural products CC(C)=CCCC(=C)C1CCC(C)=CC1 XZRVRYFILCSYSP-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 229960002246 beta-d-glucopyranose Drugs 0.000 description 1
- YOVSPTNQHMDJAG-UHFFFAOYSA-N beta-helmiscapene Natural products C1CCC(=C)C2CC(C(=C)C)CCC21C YOVSPTNQHMDJAG-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- DGZBGCMPRYFWFF-UHFFFAOYSA-N beta-trans-Bergamoten Natural products C1C2C(CCC=C(C)C)(C)C1CCC2=C DGZBGCMPRYFWFF-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- WPGPCDVQHXOMQP-UHFFFAOYSA-N carvotanacetone Natural products CC(C)C1CC=C(C)C(=O)C1 WPGPCDVQHXOMQP-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- DLNKOYKMWOXYQA-IONNQARKSA-N cathine Chemical compound C[C@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-IONNQARKSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- VLXDPFLIRFYIME-BTFPBAQTSA-N copaene Chemical compound C1C=C(C)[C@H]2[C@]3(C)CC[C@@H](C(C)C)[C@H]2[C@@H]31 VLXDPFLIRFYIME-BTFPBAQTSA-N 0.000 description 1
- TUSDEZXZIZRFGC-XIGLUPEJSA-N corilagin Chemical compound O([C@H]1[C@H](O)[C@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC[C@@H](O1)[C@H]2O)C(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-XIGLUPEJSA-N 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- AZOCECCLWFDTAP-RKDXNWHRSA-N dihydrocarvone Natural products C[C@@H]1CC[C@@H](C(C)=C)CC1=O AZOCECCLWFDTAP-RKDXNWHRSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- RBKMRGOHCLRTLZ-UHFFFAOYSA-N eicosenoic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCCCC(=O)OC RBKMRGOHCLRTLZ-UHFFFAOYSA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- IEICDHBPEPUHOB-UHFFFAOYSA-N ent-beta-selinene Natural products C1CCC(=C)C2CC(C(C)C)CCC21C IEICDHBPEPUHOB-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- MBPTXJNHCBXMBP-IGOJNLFMSA-N galanolactone Chemical compound C([C@@H]1[C@@]2(C)CCCC([C@@H]2CC[C@]11OC1)(C)C)\C=C1\CCOC1=O MBPTXJNHCBXMBP-IGOJNLFMSA-N 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- BXWQUXUDAGDUOS-UHFFFAOYSA-N gamma-humulene Natural products CC1=CCCC(C)(C)C=CC(=C)CCC1 BXWQUXUDAGDUOS-UHFFFAOYSA-N 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- TWVJWDMOZJXUID-QJPTWQEYSA-N guaiol Natural products OC(C)(C)[C@H]1CC=2[C@H](C)CCC=2[C@@H](C)CC1 TWVJWDMOZJXUID-QJPTWQEYSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- QBNFBHXQESNSNP-UHFFFAOYSA-N humulene Natural products CC1=CC=CC(C)(C)CC=C(/C)CCC1 QBNFBHXQESNSNP-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- SEZLYIWMVRUIKT-UHFFFAOYSA-N isopiperitenone Natural products CC(=C)C1CCC(C)=CC1=O SEZLYIWMVRUIKT-UHFFFAOYSA-N 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- RBKMRGOHCLRTLZ-ZHACJKMWSA-N methyl (e)-icos-11-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCCCC(=O)OC RBKMRGOHCLRTLZ-ZHACJKMWSA-N 0.000 description 1
- UQMZQVKOCCCWIL-UHFFFAOYSA-N methyl 4,8,12-trimethyltridecanoate Chemical compound COC(=O)CCC(C)CCCC(C)CCCC(C)C UQMZQVKOCCCWIL-UHFFFAOYSA-N 0.000 description 1
- 125000005911 methyl carbonate group Chemical class 0.000 description 1
- IKIGNQHSDISMLY-UHFFFAOYSA-N methyl octadecanoate;2-methyloctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC.CCCCCCCCCCCCCCCCC(C)C(O)=O IKIGNQHSDISMLY-UHFFFAOYSA-N 0.000 description 1
- 229940073769 methyl oleate Drugs 0.000 description 1
- LXXMAYBNDHTYHL-UHFFFAOYSA-N methyl platyconate-A Natural products OC1CC(C2C(C3(CC(O)C4(CCC(C)(C)CC4C3=CC2)C(=O)OC2C(C(O)C(O)CO2)OC2C(C(O)C(OC3C(C(OC4C(C(O)(CO)CO4)O)C(O)CO3)O)C(C)O2)O)C)(C)CC2)(C)C2C(C(=O)OC)(CO)C1OC1OC(CO)C(O)C(O)C1O LXXMAYBNDHTYHL-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 229940031348 multivalent vaccine Drugs 0.000 description 1
- 229940073569 n-methylephedrine Drugs 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- HXCGUCZXPFBNRD-UHFFFAOYSA-N nodakenine Natural products C1C2=CC=3C=CC(=O)OC=3C=C2OC1C(C)(C)OC1OC(CO)C(O)C(O)C1O HXCGUCZXPFBNRD-UHFFFAOYSA-N 0.000 description 1
- IORLKTZOJWQNPB-UHFFFAOYSA-N octan-3-one Chemical compound CCCCCC(=O)CC.CCCCCC(=O)CC IORLKTZOJWQNPB-UHFFFAOYSA-N 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000009835 oxypaeoniflora Substances 0.000 description 1
- FCHVXNVDFYXLIL-QYDSDWLYSA-N oxypaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@@]1(C[C@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=C(O)C=C1 FCHVXNVDFYXLIL-QYDSDWLYSA-N 0.000 description 1
- RLXWQODPAWIVOI-UHFFFAOYSA-N oxypaeoniflorin Natural products OCC1OC(OC23CC4C5(O)CC2OC(O5)C34COC(=O)c6ccc(O)cc6)C(O)C(O)C1O RLXWQODPAWIVOI-UHFFFAOYSA-N 0.000 description 1
- JMSFLLZUCIXALN-UHFFFAOYSA-N p-hydroxyphenylethyl trans-ferulate Natural products C1=C(O)C(OC)=CC(C=CC(=O)OCCC=2C=CC(O)=CC=2)=C1 JMSFLLZUCIXALN-UHFFFAOYSA-N 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- CZQNYPBIOHVQQN-UHFFFAOYSA-N phenethyl trans-ferulate Natural products C1=C(O)C(OC)=CC(C=CC(=O)OCCC=2C=CC=CC=2)=C1 CZQNYPBIOHVQQN-UHFFFAOYSA-N 0.000 description 1
- 235000019617 piquancy Nutrition 0.000 description 1
- 229930189407 platycodin Natural products 0.000 description 1
- QIRJTOQSIFZVLD-UHFFFAOYSA-N platyconic acid-A lactone Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC8OC(=O)C(CO)(C8OC9OC(CO)C(O)C(O)C9O)C7CCC6(C)C5(C)CC4O)C(O)C(O)C1OC%10OCC(O)C(OC%11OCC(O)(CO)C%11O)C%10O QIRJTOQSIFZVLD-UHFFFAOYSA-N 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000035752 proliferative phase Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 229960003908 pseudoephedrine Drugs 0.000 description 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 1
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- MOCOXAJEZKHXSF-IHMBCTQLSA-M sodium;(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound [Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MOCOXAJEZKHXSF-IHMBCTQLSA-M 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- YMBFCQPIMVLNIU-UHFFFAOYSA-N trans-alpha-bergamotene Natural products C1C2C(CCC=C(C)C)(C)C1CC=C2C YMBFCQPIMVLNIU-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- DCSCXTJOXBUFGB-UHFFFAOYSA-N verbenone Natural products CC1=CC(=O)C2C(C)(C)C1C2 DCSCXTJOXBUFGB-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- YMBFCQPIMVLNIU-GRKKQISMSA-N α-bergamotene Chemical compound C1[C@H]2C(CCC=C(C)C)(C)[C@@H]1CC=C2C YMBFCQPIMVLNIU-GRKKQISMSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine preparation for treating intensive care respiratory system infection. The medicine preparation is prepared from the following ingredients in parts by weight: 7 to 9 parts of herba ephedrae, 5 to 7 parts of radix paeoniae alba, 9 to 11 parts of fresh ginger, 5 to 7 parts of notopterygium roots, 3 to 7 parts of radix platycodonis, 7 to 9 parts of herba schizonepetae, 3 to 5 parts of affine cudweed and 13 to 15 parts of liquorice roots. The invention also provides a preparation method of the medicine preparation. The medicine preparation provided by the invention has the obvious curative effect on the intensive care respiratory system infection.
Description
Technical field
The present invention relates to pharmaceutical technology field, a kind of medicine that can be used for Intensive Care Therapy respiratory system infection
Thing preparation and preparation method thereof.
Background technology
At present, respiratory system (Respiratory System) is carried out body and the extraneous device carrying out gas exchange
The general name of official.The function of respiratory system mainly carries out gas exchange with extraneous, gives off carbon dioxide, and inhales
Enter oxygen, carry out metabolism.Respiratory system includes respiratory tract (nasal cavity, pharynx, larynx, trachea-bronchial epithelial cell)
And lung.
Respiratory system disease is a kind of commonly encountered diseases, frequently-occurring disease, major lesions trachea-bronchial epithelial cell, pulmonary and
Thoracic cavity, the many coughs of pathological changes the lighter, chest pain, breathing are impacted, and severe one dyspnea, anoxia are even breathed
Exhaustion and lethal.Mortality rate in city accounts for the 3rd, then accounts for first place in rural area.Respiratory system infection is
Class maximum, modal in respiratory system disease, its often with heating, inflammation, cough and breathe system
The pain of system.Doctor trained in Western medicine many employings antibiotic, antiviral and hormonotherapy at present, therapeutic effect is barely satisfactory,
And side effect is big, easily causes the abuse of antibiotic.The traditional Chinese medical science is thought, respiratory system infection belongs to " coughing of Chinese medicine
Cough ", " phlegm retention ", the category such as " cough with asthma ".Think that exopathogen is attacked and lung, spleen, the dirty malfunction of kidney three,
It it is the main cause causing primary disease.Human righteousness is not enough, defends outer dereliction of duty, being invaded by exogenous pathogen, and exopathogen both can be
The heresy of wind and cold, it is possible to be the heresy of wind heat, it is possible to the heresy heat-transformation of wind and cold, invades lungs, makes impaired depurative descending of lung QI;Or
Insufficiency of lung-QI, weakened defensive QI, feel exopathogen again;Or the most weak, deficiency of both the splenic and pulmonary QI, dysfunction of the spleen in transportation, wet poly-
Become expectorant, stop storing in lung;Or lung has chronic disease, feel exopathogen again;Or after prolonged illness, spleen lung undermine kidney, cause
Deficiency of kidney-QI, improving inspiration by invigorating kidney-QI is had no right.Mainly there is a following typing:
1, wind and cold bundle table.Card is shown in: aversion to wind and cold is heavier, with heating, and lossless or hypohidrosis, nasal obstruction, flow thin nasal discharge,
Sneeze, headache, limb aching pain, mouth is thirsty, or coughs and tell dilute white expectorant, hoarseness, thin white fur of tongue and moisten,
Floating and tense pulse.The rule for the treatment of: relieving the exterior syndrome with drugs of pungent in flavor and warm in nature, heating wind and cold.
2, wind heat violates table.Card is shown in: substantially, micro evil wind is trembled with fear, hypohidrosis, distending pain in the head in heating, nasal obstruction, or stream Huang
Tears, thirsty, swallow red and pain, cough, tell yellow sputum or glue expectorant in vain, tongue tip side of red, white and thin fur and dry or micro-Huang,
Floating and rapid pulse.The rule for the treatment of: relieving the exterior syndrome with drugs of pungent in flavor and cool in nature, evacuates heating.
3, heat-damp in summer attacks table.Card is shown in: sick summer, disease sees fever with aversion to cold, lossless or hypohidrosis, and giddy goes up painful,
Nasal obstruction watery nasal discharge, uncomfortable in chest, vomiting and nausea tending to vomit, tire is the most greasy or yellow greasy, relaxed and soft pulse or moisten number.The rule for the treatment of: dispelling summer-heat from superficies of the body,
Removing dampness for regulating stomach.
4, heat attacks table.Card is shown in: disease is mainly in autumn, and disease sees heating, slight chill, headache, hypohidrosis, cough
Few expectorant, thirsty, dry pharynx lip is dry, xerosis cutis, tongue tip side of red, white and thin fur and do, floating pulse.The rule for the treatment of: pungent
Cool induce sweat, sweet cold moisturize.
But, a kind of Chinese medicine preparation, it is possible to play preferably at Intensive Care Therapy respiratory system infection
Assosting effect.
Summary of the invention
Technical problem solved by the invention is to provide a kind of medicine that can be used for Intensive Care Therapy respiratory system infection
Thing preparation and preparation method thereof, thus solve the problem in above-mentioned background technology.
Technical problem solved by the invention realizes by the following technical solutions:
A kind of pharmaceutical preparation that can be used for Intensive Care Therapy respiratory system infection, including the component of following weight portion:
Herba Ephedrae 7-9 part;
Radix Paeoniae Alba 5-7 part;
Rhizoma Zingiberis Recens 9-11 part;
Rhizoma Et Radix Notopterygii 5-7 part;
Radix Platycodonis 3-7 part;
Herba Schizonepetae 7-9 part;
Mus grass 3-5 part;
Radix Glycyrrhizae 13-15 part.
In the present invention, as the preferred technical scheme of one, one can be used for Intensive Care Therapy respiratory system infection
Pharmaceutical preparation, the component of following weight portion be prepared from:
8 parts of Herba Ephedrae;
The Radix Paeoniae Alba 5 parts;
10 parts of Rhizoma Zingiberis Recens;
Rhizoma Et Radix Notopterygii 6 parts;
Radix Platycodonis 5 parts;
Herba Schizonepetae 8 parts;
Mus grass 5 parts;
14 parts of Radix Glycyrrhizae.
In the present invention, as the preferred technical scheme of one, the preparation method of this pharmaceutical preparation, including as follows
Step:
(1) Herba Ephedrae is sieved, remove impurity, be placed in mill groove, grind loosen into fiber velvet-like;By the Radix Paeoniae Alba
Being soaked in water to eighty per cant thoroughly, pull out, solarization is dried in the air, and profit to inside and outside humidity is uniform, section, then puts interior the stir-fry of pot
To coke yellow, spray clear water is a little, takes out, dries;Take fresh ginger, clean, mash, squeeze extracting juice,
Stand, divide the opaque taking precipitation, cold drying, obtain powder, then weigh;By Herba Schizonepetae cutting, put
In pot, micro-stir-fry at 70-90 DEG C, taking-up cools;Radix Glycyrrhizae section is added cooked Mel and a little boiled water, mixes
After even the most vexed, put fry in pot to buff and tack-free time, take out and dry in the air cool, grind to form 50-60 mesh powder;
(2) weigh step (1) obtain Herba Ephedrae, the Radix Paeoniae Alba, Rhizoma Zingiberis powder, mix homogeneously, grind to form 30-50
Purpose powder, then will add the distilled water of 10-15 times of weight, reflux, extract, at 80-85 DEG C in powder
30-45 minute, then stand cooling, be filtrated to get supernatant;
(3) Herba Schizonepetae obtained, and Rhizoma Et Radix Notopterygii, Radix Platycodonis and Mus are processed by supernatant adds step (1)
Grass, boils 20-35 minute, refluxes, then filter, obtain filtrate when boiling, and will add step (1) in filtrate
The Radix Glycyrrhizae powder obtained, stirring mixing, obtain pharmaceutical preparation.
The pharmaceutical preparation that the present invention provides, when taking, three times a day, each takes 35-55ml, after taking again
Drink the warm water of at least 100ml.
In the present invention, Herba Ephedrae, [nature and flavor] hardship pungent, micro-, temperature.[return through] returns lung, bladder warp.[function master
Control] diaphoresis cold expelling, depressed lung-energy dispersing, inducing diuresis to remove edema.For anemofrigid cold, uncomfortable in chest breath with cough, edema due to wind pathogen edema;
Bronchial asthma.Herba ephedrae nourishing the lung to arrest cough.It is used for table disease to solve, asthma and cough.Caulis Ephedrae containing alkaloid 1~
2%, wherein 40~90% is ephedrine, is secondly the l-N-methylephedrine of pseudoephedrine and trace, d-N-
Methyl pseudoephedrine, l-demethyl ephedrine, d-Nor pseudo ephedrine, ephedine;Again containing catechotannin
6% and volatile oil, containing l-alpha-terpineol in volatile oil.Test proves, Herba Ephedrae has antitussive effect.Use histamine
Aerosol causes to breathe heavily method test, and mouse peritoneal injection Herba Ephedrae volatile oil 0.1ml/kg has antiasthmatic effect, and Herba Ephedrae is volatilized
The line of oils mice cause time of breathing heavily is 7.2 ± 2.1 minutes, and normal saline group is 2.2 ± 0.7 minutes (P < 0.05).
The test of phenol red method finds have, to mouse stomach Herba Ephedrae volatile oil 0.4ml/kg, the effect promoting that trachea excretion is phenol red.
Meanwhile, also there is antibiosis and antiviral functions: teamster's tea in vitro tests is to staphylococcus aureus, first kind chain
Coccus, second kind streptococcus, charcoal trace bacillus, diphtheria corynebacterium, bacillus pyocyaneus, dysentery bacterium, Bacillus typhi table
Antibacterial action the most in various degree.Herba Ephedrae volatile oil is to hemophilus influenza, escherichia coli, Candida albicans ball
Bacterium all has bacteriostasis in various degree, and Asia influenza A virus is had inhibitory action, sick to influenza A
Poison PR, the mice that strain is infected has therapeutical effect.Teamster's tea is dense to the minimum suppression of Asia influenza A virus
Degree is 2mg/ml.
The Radix Paeoniae Alba, [nature and flavor] are bitter, sour, are slightly cold.[return through] returns liver, spleen channel.[function cures mainly] suppressing the hyperactive liver pain relieving,
Nourishing blood for regulating menstruation, astringing YIN to stop sweating.For dizziness of having a headache, hypochondriac pain, stomachache, limb pain twin, blood deficiency and yellow complexion, the moon
Through uncomfortable, spontaneous perspiration, night sweat.Root contains paeoniflorin, paeonol, paeoniflorin, benzoic acid about 1.07%, waves
Hair oil, fatty oil, resin, tannin, sugar, starch, phlegmatic temperament, protein, cupreol and triterpenes.
Another Sichuan product person, containing a kind of acidic materials, has inhibitory action to staphylococcus aureus.Flower is containing astragalin, mountain
Naphthol 3,7-diglucoside, volume gallotannin (more than 10%), pyrethrin 0.13%, 13-first
Base tetradecanoic acid, cupreol, pentacosane etc..Leaf contains tannin.[pharmacological action] has antibacterial action.Chinese herbaceous peony
Medicine or paeoniflorin have more weak antiinflammatory action, to yeast, chondrus ocellatus Holmes colloidality and dextran pedal swelling
There is inhibitory action in various degree, share synergism with licorice ingredient FM100, abdominal cavity blood capillary is led to
Property also has more weak inhibitory action thoroughly.Rat Ovum Gallus domesticus album acute inflammation and granuloma induced by implantation of cotton pellets are all had by Radix Paeoniae Alba extract
Inhibitory action.White peony root's total glycoside 50mg/kg, every day 1 time, continuous 11 days, closes Rat Experimental adjuvanticity
Joint inflammation has obvious inhibiting effect.In Radix Paeoniae, contained paeonol, benzoylpaeoniflorin and oxypaeoniflorin also have anti-
Scorching effect.Paeoniflorin has preventive effect to rat stress ulcer, share with FM100 at pylorus-ligated rats
In terms of suppression gastric secretion, there is synergism, but Radix Paeoniae extracting solution makes gastric acidity slightly rise.
Rhizoma Zingiberis Recens, [nature and flavor] are pungent, tepor.[return through] returns lung, spleen, stomach warp.[function cures mainly] relieving exterior syndrome and dispelling cold,
Warming middle-JIAO to arrest vomiting, preventing phlegm from forming and stopping coughing.For anemofrigid cold, gastrofrigid vomiting, cold-phlegm is coughed.Rhizoma Zingiberis Recens becomes containing volatility
Point: α-zingiberene (α-zingiberene), β-santalol (β-santalol), β-phellandrene
(β-phellandrene), β-bisabolence (β-bisabolene), α-curcumene (α-curcumene), zingiberol
(zingiberol), perillaldehyde (perillaldehyde), neral (neral), geranial (geranial), 2-carane
Alcohol (2-caraneol), 3-carol, lauro lene (camphene), β-ocimene (β-ocimene), α-bergmot oil alkene
(α-bergamotene), β-gold just joyous alkene (β-farnesene), myrcene (myrcene), nopinene
(β-pinene), 2-Borneolum Syntheticum (2-borneol), citral (citral), 7-alkene in the Meng [7-menthene], different fenchol
(isofenchyl alcohol), α-farnesene, 1,3,3-trimethyl three ring [2.2.1.02,6]-heptane [1,3,
3-trimethyltricyclo [2.2.1.02,6] heptane], 2,6-dimethyl-6-(4-methyl-3-pentenyl)-bicyclo-
[3.1.1]-2-heptane [2,6-dimethyl-6-(4-methyl-3-pentenyl)-bicyclo [3.1.1]-2-heptene], 1,
3,3-trimethyl-2-oxabicyclo [2.2.2] octanes [1,3,3-trimethyl-2-oxabicyclo [2.2.2] octane],
1-(1,5-dimethyl-4-vinyl)-4-methylbenzene [1-(1,5-eimethyl-4-hexenyl)-4-methylbenzene]
And tens of kinds of Rhizoma Alpiniae Officinarum terpene lactones (galanolactone) etc.;Piquancy component: the peppery alcohol of 6-Rhizoma Zingiberis Recens (6-gingerol), 3-
The peppery alcohol of Rhizoma Zingiberis Recens, the peppery alcohol of 4-Rhizoma Zingiberis Recens, the peppery alcohol of 5-Rhizoma Zingiberis Recens, the peppery alcohol of 8-Rhizoma Zingiberis Recens, the peppery alcohol of 10-Rhizoma Zingiberis Recens, the peppery alcohol of 12-Rhizoma Zingiberis Recens, the peppery glycol of 6-Rhizoma Zingiberis Recens
(6-gingediol), the peppery glycol of 4-Rhizoma Zingiberis Recens, the peppery glycol of 8-Rhizoma Zingiberis Recens, the peppery glycol of 10-Rhizoma Zingiberis Recens, the peppery glycol of 6-methyl Rhizoma Zingiberis Recens
(6-gingediol), the peppery glycol of 4-Rhizoma Zingiberis Recens, the peppery glycol of 8-Rhizoma Zingiberis Recens, the peppery glycol of 10-Rhizoma Zingiberis Recens, the peppery glycol of 6-methyl Rhizoma Zingiberis Recens
(6-methylgingediol), 4-Rhizoma Zingiberis Recens peppery glycol diacetate (4-gingediacetate), 6-Rhizoma Zingiberis Recens peppery glycol diacetic acid
Ester, 6-methyl Rhizoma Zingiberis Recens glycol diacetic acid (6-methylgingediacetate), the peppery diketone of 6-Rhizoma Zingiberis Recens (6-gingerdione),
The peppery diketone of 10-Rhizoma Zingiberis Recens, the peppery diketone of 6-dehydrogenation Rhizoma Zingiberis Recens (6-dehydrogingerdiong), the peppery diketone of 10-dehydrogenation Rhizoma Zingiberis Recens, 6-second
The peppery alcohol of acyl Rhizoma Zingiberis Recens (6-acetylgingerol), the peppery ketenes of 6-Rhizoma Zingiberis Recens (6-shogaol) etc..Rhizoma Zingiberis Recens is to circulation and the work of breathing
With: normal person's chewing Rhizoma Zingiberis Recens 1g (not swallowing), contraction can be made to flatten all and to raise 11.2mm mercury column, diastolic pressure
Rise 14mm mercury column, to pulse frequency then without significant impact.Alcoholic extract to anesthetized cat vasomotor center and
Respiratory center has excitation, also has direct excitation to heart.
Rhizoma Et Radix Notopterygii, [nature and flavor] are pungent, bitter, temperature.[return through] returns bladder, kidney channel.[function cures mainly] cold expelling,
Dispel the wind, dehumidifying, pain relieving.Have a headache for anemofrigid cold, rheumatic arthralgia, aching pain in shoulder and back.Rhizoma Et Radix Notopterygii rhizome is containing perfume
Bean essence compounds: different imperatorin (isoimperatorin0.38%), the different imperatorin of 8-methoxyl group
(cnidilin0., 5-hydroxyl bergmot element (notopterol1.2%), bergapten (bergapten0.009%), 8-
(3,3-dimethyl-allyl)-5 demethyl bergapten (demethylfuroinnarin) i.e. 5-hydroxyl-8-(3,
3-dimethyl thiazolinyl)-psoralen [5-hydroxy-8 (3,3-dimethylally)-psoralen, 0.012%],
5-demethyl bergmot alcohol (bergaptol0.088%), decuroside unit (nodakenetin0.04%), pale reddish brown
Radix Peucedani glycoside (nodakenin trace), bergmot alcohol-O-β-D-Glucopyranose.
(bergaptol-O-β-D-glucopyranoside0.075%), 6-O-trans-Resina Ferulae acyl decuroside
(6-O-trans-feruloylnodakenin0.022%) [1], columbianetin (colrmbianetin), dihydro mountain
Celery alcohol glycoside (columbiananine), imperatorin (imperatorin), India's element (marmesin) [2];
Phenoloid: p-leptodactyline Fructus Foeniculi acid esters (p-hydroxyphenethyl anisate0.005%), Ah
Acid Wei (ferulic acid0.89%);Phytosterin compound: cupreol glycoside (β-sitosterol
Glucoside) [1], cupreol (β-sitosterol) [2];Volatile oil (about 2.7%), its composition has α-side
Cupressene (α-thujene), α and nopinene (α, β-pinene), β ocimene (β-ocimene),
γ-terpinene (γ-terpinene), limonene (limonene), 4-terpinenol (4-terpinenol), acetic acid
Borneol acetate (bornylacetate), α-(king is ancient) (king's bar) alkene (α copaene), trans-β-farnesene
(β-farnesene), parsley brain (apiol), guiol (guaiol) and benzyl benzoate (benzylbenzoate)
Deng [3];Fatty acid: ten tetra-carbonic methyl ester (methyltetradecanoate), 12-methyl ten tetra-carbonic methyl ester
(12-methyltetradecanoic acid methyl ester), Palmitic acid methyl ester
(methylhex-adecanoate), 4,8,12-trimethyl ficocerylic acid methyl ester (4,8,
12-trimethyl-tridecanoic acid methyl ester), 14-methyl Palmitic acid methyl ester
(14-methyl-hexadecanoic acid methyl ester), methyl oleate (methyl-9-octadecenoate),
Methyl stearate (methyloctadecanoate), 20 methyl carbonates (methyleicosanoate), 11-20
Carbon enoic acid methyl ester (methyl-11-eicosenoate) etc. 14 kinds;Amino acids: aspartic acid (aspartic acid),
Glutamic acid (glutamic acid), thick ammonia alcohol (arginine), leucine (leucine), isoleucine (isoleucine),
Valine (valine), threonine (threonine), phenylalanine (phenylalanine) and methionine
Etc. (methyionine) 19 kinds;Saccharide, rhamnose (rhamnose), fructose (fructose), glucose (glucose)
And sucrose (sucrose) [4].Rhizoma Et Radix Notopterygii also (phenethylferulate) Han phenethyl ferulic acid ester [5] .2. Kuan Ye Qiang
Under ground portion compound Han Coumarins alive: bergmot element (berg-amottin, bergaptin), different imperatorin
(the different imperatorin of 0.62%, 8-methoxyl group (0.024%), 5-gate of a lane basic note chess element (0.083%), in bergmot
Ester (0.008%), and 8-(3,3-dimethyl-allyl-5-de-methoxy bergapten (0.03%), bergmot alcohol
(0.026%), decuroside unit (0.053) %, decuroside (1.2) %, 6-O-trans-Resina Ferulae acyl
Decuroside (0.73) %, columbianetin;Phenoloid;P-hydroxyphenylmethyl anisic acid (0.07%),
Ferulic acid (0.83%).Also containing cupreol glycoside and volatile oil, volatile oil is mainly composed of australene
Alkene (36.30%), nopinene (21.04%), limonene (14.42%), additionally, also have aldehyde (hexanal),
Enanthaldehyde (heptanal), octanal (octanal), sabinene (sabinene), lauro lene (camphene), Laurel
Alkene (myrcene), α-phellandrene (α-phellandrene), 3-carene (3-carene), 2-carene (2-carene),
Cymol (p-cymene), α, γ-terpinene, 4-terpinenol, borneol acetate and β-celery
20 kinds of alkene (β-selinene) etc..There is preferable antiinflammatory refrigeration function.Test proves, pyrogenicity to yeast
The impact of rat temperature: 2.5h after rat skin lower injection l5% yeast suspension 10ml/kg pyrogenicity, then distinguishes
With Rhizoma Et Radix Notopterygii volatile oil 1.328ml/kg gavage and 0.133ml/kg gastric infusion, after administration, different time surveys rat
Body temperature.Result and the volatile oil comparing two kinds of different approaches and various dose all can make rat temperature obvious
Reduce, there is significant refrigeration function.Impact on mice dimethylbenzene dropsy of ear: mice gavage Rhizoma Et Radix Notopterygii respectively
Volatile oil 1.328,0.664,0.332,0.221ml/kg, after administration, auris dextra melted paraxylene 0.03ml/ is only,
Calculate left and right auricle weight difference (mg).Result compares with matched group (12.5 ± 6.01), be respectively as follows: 6.6 ± 4.40,
7.2±3.16、7.0±4.21、15.9±5.28.Front 3 dosage groups compare P < 0.05 with matched group.Show
Can significant suppression dimethylbenzene dropsy of ear.The impact of Carrageenan foot swelling: Oral Administration in Rats 1.328,0.664ml
/ kg or lumbar injection 0.133,0.066ml/kg have suppression to Rat Carrageenan (1%0.1ml) foot swelling
Effect.Compare with matched group and 1.328ml/kg group injection carrageenin after 3 or 4 hour P < 0.05 be administered orally,
Oral 0.664ml/kg group 24 little P constantly < 0.001, lumbar injection 0.133ml/kg group 24 hours, P
< 0.05.Impact on rat dextran foot swelling: Oral Administration in Rats Rhizoma Et Radix Notopterygii volatile oil 1.328,0.664,
0.332ml/kg, in rat hindleg plantar aponeurosis hemostasis 1.2% dextran 0.1ml/ is only administered latter 30 minutes.
Result compares with matched group, only 1.328ml/kg group, has significant difference in 3,5,6 little inhibitory action constantly
Different P < 0.05.
Radix Platycodonis, [nature and flavor] are bitter, pungent, flat.[return through] returns lung meridian.[function cures mainly] lung qi dispersing, sore-throat relieving, dispel
Expectorant, evacuation of pus.For cough with copious phlegm, uncomfortable in chest not smooth, pharyngalgia, hoarseness, lung abscess vomiting pus, skin infection difficulty in discharging of pus.
Radix Platycodonis is utilized to test, after anesthetized dog is administered orally decoct 1 g/kg, the significant increase of respiratory mucus secretory volume,
Action intensity can be compared with ammonium chloride.Separately have been reported that and think that its effect is better than Radix Polygalae and is inferior to senea, and use
During phenol red excretion algoscopy, its effect is more weak than Radix Polygalae.To anesthetized cat, also have and promote respiratory mucus secretion
Effect.Phlegm-dispelling functions, mainly due to caused by Saponin contained therein, can stimulate gastric mucosa time low dose of, draw
Play mild nausea, thus increase bronchial secretion reflectingly.According to the comparison that haemolysis is strong and weak, it is believed that
Wild Radix Platycodonis is stronger than the effect of cultivation, unpeeled more much better than than the effect of peeling, the work that pale reddish brown ratio is spent in vain
With slightly larger, the effect growing 2 years is the strongest, and 1 year take second place, the effect of 3 years is minimum.Compared with Radix Polygalae, Fructus Citri tangerinae
The haemolysis of stalk is more weak.Containing multiple Saponin, the most having got 18 kinds of triterpenoid saponin, they are;Radix Platycodonis soap
Glycoside (platycodin) A, C, D [1], D2, D3, remove celery glycosyl kikyosaponin (deapioplatycodin)
D, D3,2-O-=acetyl group kikyosaponin (2-O-acetylplatycodin) D2,3-O-acetyl group Radix Platycodonis soap
Glycoside (3-O-acetylplaty-codin) D2, polygalin (polyglalacin) D, D2,2-O-acetyl group is remote
Will Saponin (2-O-acetylpolygalacin) D, D2,3-O-acetyl group polygalin
(3-O-acetylpolygalacin) D, D2, Radix Platycodonis glycoside acid-A methyl ester (methyl platyconate-A), 2-O-
Methyl Radix Platycodonis glycoside acid-A methyl ester (methyl-2-O-methyplatyconate-A), Radix Platycodonis glycoside acid-A lactone
(platyconic acid-A lactone).Have and significantly eliminate the phlegm and antitussive effect: anesthetized dog is administered orally this product decoct
1g/kg, the secretory volume of the significant increase respiratory mucus of energy, its intensity can be compared with ammonium chloride.To anesthetized cat also
There is obvious phlegm-dispelling functions.Have been reported that the phlegm-dispelling functions of kikyosaponin is better than Radix Polygalae, inferior to senea (Poygala
senegaL.).Mice phenol red method result of the test is then weaker than Radix Polygalae.When contained by Radix Platycodonis, Saponin is administered orally, throat is glued
Film and gastric mucosa cause stimulation to a certain degree, cause respiratory mucosa hypersecretion reflectingly, make sputum dilute
Releasing, promote it to discharge, rough kikyosaponin has antitussive effect.Guinea pig intraperitoneal injection and antitussive median effective dose
For 6.4mg/kg.
Herba Schizonepetae, [nature and flavor] are pungent, tepor.[return through] returns lung, Liver Channel.[function cures mainly] induces sweat scattered wind, thoroughly
Rash.For catching a cold, headache, measles, rubella, skin infection from the beginning of.Parch to black treating hematochezia, metrorrhagia, puerperal blood faints.
The aerial parts of Herba Schizonepetae, fringe, GENGGE contain volatile oil 1.12%, 1.69%, 0.60%, and wherein main component is equal
For pulegone (pule-gone), menthone (menthone), isomenthone (isomenthone) and different Hu
Menthone (isopulegone);Also contain: ethyl pentyl group ether (1-ethoxypentane), 3-methyl ring penta
Ketone (3-methylcyclopentanone), 3-methylcyclohexanone (3-methylcy-clohexanone), benzaldehyde
(benzaldehyde), 1-OCOL (1-octen-3-ol), 3-octanone (3-octanone), 3-capryl alcohol
(3-octanol), P-cymene (cymene), limonene (limonene), neomenthol (neomenthol),
Menthol (menthol), piperitone (piperitone), Mentha piperita ketenes (piperitenone), oxalene
(humulene), Flos Caryophylli alkene (caryophyllene);Possibly together with nopinene in aerial parts volatile oil
(β-pinene), 3,5-dimethyl-2-cyclohexene-1-ketone (3,5-dimethyl-2-cyclohexen-1-one), second
Thiazolinyl dimethylbenzene (ethenyl dimethyl benzene), cineole (cineole), Eucarvone (carvone),
Dihydro Xun thread ketone (dihydrocarvone), cordovan life oxalene ketone (verbenone) [1].Spike contains monoterpene
Constituents: Herba Schizonepetae glycoside (schizoneptoside) A, B [2], C, E [4], nepetol (schizonol) Herba Schizonepetae two
Alcohol (schizoneodiol) [4];Flavones ingredient: diosmetin (diosmetin), hesperidin i.e. hesperetin-7-O-
Rutinoside (hesperidin, hesperetin-7-O-rutinoside).Herba Schizonepetae has antipyretic effect: by wound
Cold polyvalent vaccine makes fever in rabbits, gives Schizonepeta tenuifolia decoct or ethanol preserved material 2g/kg gavage, the faintest
Refrigeration function.Herba Schizonepetae decoct has antipyretic effect.D-menthone in Herba Schizonepetae is analgesic main component,
3-methyl cyclohexanone also has analgesic activity.Resisting pathogenic microbes effect: Herba Schizonepetae decoct in vitro tests is to golden yellow Portugal
Grape coccus and diphtheria corynebacterium have stronger antibacterial action.Secondly to anthrax bacillus, group B streptococcus, typhoid fever bar
Bacterium, dysentery bacterium, bacillus pyocyaneus, Bacillus tuberculosis etc. all show certain inhibitory action.50% Herba Schizonepetae is decocted
Agent every Embryo Gallus domesticus 0.1ml is to influenza A virus PR8 strain unrestraint effect.
Mus grass, [nature and flavor] sweet in the mouth;Micro-acid;Property flat.[return through] returns lung meridian.[function cures mainly] only reduces phlegm
Cough;Expelling wind and removing dampness;Removing toxic substances.Main cough with asthma abundant expectoration;Rheumatic arthralgia;Have loose bowels;Edema;Favism;Red and white leukorrhea
Under;Carbuncle furuncle;Scrotum pruritus due to damp pathogen;Urticaria;Hypertension.[chemical composition] herb contains 5% flavonoid glycoside,
0.05% volatile oil, Alkaloid and sterol, 0.58% non-shoulders compound, again containing vitamin B, Radix Dauci Sativae,
Chlorophyll, resin, fat etc..Flower is containing luteolin-4-β-D-Glucose glycoside
(luteline-4-β-D-glucoside).Antitussive effect: after mice sucks strong aqua ammonia formation chronic cough repeatedly,
Gavage Herba Gnaphalii Affinis decoct, have certain antitussive action.Decoct 4g/kg mouse stomach, has antitussive effect.Antibacterial
Effect: 100% decoct flat board burrows method, and staphylococcus aureus, S. sonnei are had inhibitory action.
Radix Glycyrrhizae, [nature and flavor] are sweet, flat.[return through] GUIXIN, lung, spleen, stomach warp.[function cures mainly] spleen reinforcing
QI invigorating, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.For weakness of the spleen and stomach, fatigue and weakness,
Shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, extremity contraction urgency pain, carbuncle sore tumefacting virus, cushion toxicity, strong.
Antiinflammatory and antiallergic action: enoxolone is to the granuloma induced by implantation of cotton pellets of rat, formaldehyde edema, tuberculin
Reaction, subcutaneous granulation capsule inflammation all have inhibitory action.Ammonium glycyrrhizinate, Monosodium glycyrrhetin can effectively affect skin
The phase of oozing out of lower granulation capsule inflammation and proliferative phase, its action intensity is weaker than or close to cortisone.Glycyrrhizic acid
The antiinflammatory action of various preparations, the activity with succinate is higher, but toxicity is the biggest.Radix Glycyrrhizae antiinflammatory resistance
The principle of state reaction illustrates the most completely.Radix Glycyrrhizae has phlegm-dispelling functions, can promote throat and bronchial secretion,
Expectorant is made easily to bring up.
Owing to have employed above technical scheme, the method have the advantages that
In the pharmaceutical preparation of the present invention, with Herba Ephedrae, the Radix Paeoniae Alba, Rhizoma Zingiberis Recens as monarch drug, play depressed lung-energy dispersing, reduce phlegm
Effect of cough-relieving, has the most crucial effect for Intensive Care Therapy patients with respiratory tract infections;With Rhizoma Et Radix Notopterygii,
Radix Platycodonis is ministerial drug, the effect that auxiliary plays removing toxic substances, eliminates the phlegm, and prevents Intensive Care Therapy respiratory system infection further
The degree of depth that patient causes because of abundant expectoration infects;With Herba Schizonepetae, Mus grass as adjuvant drug, induce sweat scattered wind, play antiviral,
The effect of antipyretic, analgesic, make Intensive Care Therapy patients with respiratory tract infections from pain, the hardship of heating, with sweet
Grass, for making medicine, makes expectorant easily bring up, meanwhile, and coordinating the actions of various ingredients in a prescription.
The pharmaceutical treatment of the present invention 120 example Intensive Care Therapy patients with respiratory tract infections are randomly divided into treatment group and
Each 60 examples of matched group.Treatment 19 years old group age~65 years old, average course of disease is 35.7 hours.Matched group 60
Example, at 21.34 years old age, average course of disease is 34 hours.
On the basis of infection, the Primary Care such as eliminate the phlegm are identical, treatment group takes what the present invention provided
Pharmaceutical preparation, three times a day, each takes 35-55ml, drinks the warm water of at least 100ml after taking again;Right
The warm water of respective amount is given according to group.Two groups the most three times a day, within 7 days, was 1 course for the treatment of.
Result shows: treatment group total effective rate 93.1%, is significantly higher than matched group 82.4% (P < 0.05), it was demonstrated that
The pharmaceutical preparation that the present invention provides is curative effect affirmative in Intensive Care Therapy patients with respiratory tract infections, and untoward reaction
Few.
Detailed description of the invention
For the technological means making the present invention realize, creation characteristic, reach purpose and be easy to understand with effect,
Below in conjunction with specific embodiment, the present invention is expanded on further.
Embodiment 1
A kind of pharmaceutical preparation that can be used for Intensive Care Therapy respiratory system infection, including the component of following weight portion:
7 parts of Herba Ephedrae;The Radix Paeoniae Alba 5 parts;9 parts of Rhizoma Zingiberis Recens;Rhizoma Et Radix Notopterygii 5 parts;Radix Platycodonis 3 parts;Herba Schizonepetae 7 parts;Mus grass
3 parts;13 parts of Radix Glycyrrhizae.
The preparation method of this pharmaceutical preparation, comprises the steps:
(1) Herba Ephedrae is sieved, remove impurity, be placed in mill groove, grind loosen into fiber velvet-like;By the Radix Paeoniae Alba
Being soaked in water to eighty per cant thoroughly, pull out, solarization is dried in the air, and profit to inside and outside humidity is uniform, section, then puts interior the stir-fry of pot
To coke yellow, spray clear water is a little, takes out, dries;Take fresh ginger, clean, mash, squeeze extracting juice,
Stand, divide the opaque taking precipitation, cold drying, obtain powder, then weigh;By Herba Schizonepetae cutting, put
In pot, micro-stir-fry at 70 DEG C, taking-up cools;Radix Glycyrrhizae section is added cooked Mel and a little boiled water, mixes thoroughly
After the most vexed, put fry in pot to buff and tack-free time, take out and dry in the air cool, grind to form 50 mesh powder;
(2) weigh step (1) obtain Herba Ephedrae, the Radix Paeoniae Alba, Rhizoma Zingiberis powder, mix homogeneously, grind to form 30 purposes
Powder, then will in powder add 10 times of weight distilled water, reflux, extract, 30 minutes at 80 DEG C, so
Rear standing is lowered the temperature, and is filtrated to get supernatant;
(3) Herba Schizonepetae obtained, and Rhizoma Et Radix Notopterygii, Radix Platycodonis and Mus are processed by supernatant adds step (1)
Grass, boils 20 minutes, refluxes, then filter, obtain filtrate when boiling, and will add step (1) in filtrate
The Radix Glycyrrhizae powder obtained, stirring mixing, obtain pharmaceutical preparation.
Embodiment 2
A kind of pharmaceutical preparation that can be used for Intensive Care Therapy respiratory system infection, including the component of following weight portion:
9 parts of Herba Ephedrae;The Radix Paeoniae Alba 7 parts;11 parts of Rhizoma Zingiberis Recens;Rhizoma Et Radix Notopterygii 7 parts;Radix Platycodonis 7 parts;Herba Schizonepetae 9 parts;Mus
Grass 5 parts;15 parts of Radix Glycyrrhizae.
The preparation method of this pharmaceutical preparation, comprises the steps:
(1) Herba Ephedrae is sieved, remove impurity, be placed in mill groove, grind loosen into fiber velvet-like;By the Radix Paeoniae Alba
Being soaked in water to eighty per cant thoroughly, pull out, solarization is dried in the air, and profit to inside and outside humidity is uniform, section, then puts interior the stir-fry of pot
To coke yellow, spray clear water is a little, takes out, dries;Take fresh ginger, clean, mash, squeeze extracting juice,
Stand, divide the opaque taking precipitation, cold drying, obtain powder, then weigh;By Herba Schizonepetae cutting, put
In pot, micro-stir-fry at 90 DEG C, taking-up cools;Radix Glycyrrhizae section is added cooked Mel and a little boiled water, mixes thoroughly
After the most vexed, put fry in pot to buff and tack-free time, take out and dry in the air cool, grind to form 60 mesh powder;
(2) weigh step (1) obtain Herba Ephedrae, the Radix Paeoniae Alba, Rhizoma Zingiberis powder, mix homogeneously, grind to form 50 purposes
Powder, then will in powder add 15 times of weight distilled water, reflux, extract, 45 minutes at 85 DEG C, so
Rear standing is lowered the temperature, and is filtrated to get supernatant;
(3) Herba Schizonepetae obtained, and Rhizoma Et Radix Notopterygii, Radix Platycodonis and Mus are processed by supernatant adds step (1)
Grass, boils 35 minutes, refluxes, then filter, obtain filtrate when boiling, and will add step (1) in filtrate
The Radix Glycyrrhizae powder obtained, stirring mixing, obtain pharmaceutical preparation.
Embodiment 2
A kind of pharmaceutical preparation that can be used for Intensive Care Therapy respiratory system infection, including the component of following weight portion:
8 parts of Herba Ephedrae;The Radix Paeoniae Alba 5 parts;10 parts of Rhizoma Zingiberis Recens;Rhizoma Et Radix Notopterygii 6 parts;Radix Platycodonis 5 parts;Herba Schizonepetae 8 parts;
Mus grass 5 parts;14 parts of Radix Glycyrrhizae.
The preparation method of this pharmaceutical preparation, comprises the steps:
(1) Herba Ephedrae is sieved, remove impurity, be placed in mill groove, grind loosen into fiber velvet-like;By the Radix Paeoniae Alba
Being soaked in water to eighty per cant thoroughly, pull out, solarization is dried in the air, and profit to inside and outside humidity is uniform, section, then puts interior the stir-fry of pot
To coke yellow, spray clear water is a little, takes out, dries;Take fresh ginger, clean, mash, squeeze extracting juice,
Stand, divide the opaque taking precipitation, cold drying, obtain powder, then weigh;By Herba Schizonepetae cutting, put
In pot, micro-stir-fry at 80 DEG C, taking-up cools;Radix Glycyrrhizae section is added cooked Mel and a little boiled water, mixes thoroughly
After the most vexed, put fry in pot to buff and tack-free time, take out and dry in the air cool, grind to form 55 mesh powder;
(2) weigh step (1) obtain Herba Ephedrae, the Radix Paeoniae Alba, Rhizoma Zingiberis powder, mix homogeneously, grind to form 40 purposes
Powder, then will in powder add 13 times of weight distilled water, reflux, extract, 40 minutes at 83 DEG C, so
Rear standing is lowered the temperature, and is filtrated to get supernatant;
(3) Herba Schizonepetae obtained, and Rhizoma Et Radix Notopterygii, Radix Platycodonis and Mus are processed by supernatant adds step (1)
Grass, boils 30 minutes, refluxes, then filter, obtain filtrate when boiling, and will add step (1) in filtrate
The Radix Glycyrrhizae powder obtained, stirring mixing, obtain pharmaceutical preparation.
Embodiment 4
A kind of pharmaceutical preparation that can be used for Intensive Care Therapy respiratory system infection, including the component of following weight portion:
7 parts of Herba Ephedrae;The Radix Paeoniae Alba 7 parts;9 parts of Rhizoma Zingiberis Recens;Rhizoma Et Radix Notopterygii 7 parts;Radix Platycodonis 5 parts;Herba Schizonepetae 8 parts;Mus
Grass 3 parts;15 parts of Radix Glycyrrhizae.
The preparation method of this pharmaceutical preparation, comprises the steps:
(1) Herba Ephedrae is sieved, remove impurity, be placed in mill groove, grind loosen into fiber velvet-like;By the Radix Paeoniae Alba
Being soaked in water to eighty per cant thoroughly, pull out, solarization is dried in the air, and profit to inside and outside humidity is uniform, section, then puts interior the stir-fry of pot
To coke yellow, spray clear water is a little, takes out, dries;Take fresh ginger, clean, mash, squeeze extracting juice,
Stand, divide the opaque taking precipitation, cold drying, obtain powder, then weigh;By Herba Schizonepetae cutting, put
In pot, micro-stir-fry at 70 DEG C, taking-up cools;Radix Glycyrrhizae section is added cooked Mel and a little boiled water, mixes thoroughly
After the most vexed, put fry in pot to buff and tack-free time, take out and dry in the air cool, grind to form 55 mesh powder;
(2) weigh step (1) obtain Herba Ephedrae, the Radix Paeoniae Alba, Rhizoma Zingiberis powder, mix homogeneously, grind to form 45 purposes
Powder, then will in powder add 12 times of weight distilled water, reflux, extract, 40 minutes at 82 DEG C, so
Rear standing is lowered the temperature, and is filtrated to get supernatant;
(3) Herba Schizonepetae obtained, and Rhizoma Et Radix Notopterygii, Radix Platycodonis and Mus are processed by supernatant adds step (1)
Grass, boils 25 minutes, refluxes, then filter, obtain filtrate when boiling, and will add step (1) in filtrate
The Radix Glycyrrhizae powder obtained, stirring mixing, obtain pharmaceutical preparation.
Embodiment 5
A kind of pharmaceutical preparation that can be used for Intensive Care Therapy respiratory system infection, including the component of following weight portion:
9 parts of Herba Ephedrae;The Radix Paeoniae Alba 5 parts;10 parts of Rhizoma Zingiberis Recens;Rhizoma Et Radix Notopterygii 5 parts;Radix Platycodonis 7 parts;Herba Schizonepetae 8 parts;Mus
Grass 5 parts;13 parts of Radix Glycyrrhizae.
The preparation method of this pharmaceutical preparation, comprises the steps:
(1) Herba Ephedrae is sieved, remove impurity, be placed in mill groove, grind loosen into fiber velvet-like;By the Radix Paeoniae Alba
Being soaked in water to eighty per cant thoroughly, pull out, solarization is dried in the air, and profit to inside and outside humidity is uniform, section, then puts interior the stir-fry of pot
To coke yellow, spray clear water is a little, takes out, dries;Take fresh ginger, clean, mash, squeeze extracting juice,
Stand, divide the opaque taking precipitation, cold drying, obtain powder, then weigh;By Herba Schizonepetae cutting, put
In pot, micro-stir-fry at 70-90 DEG C, taking-up cools;Radix Glycyrrhizae section is added cooked Mel and a little boiled water, mixes
After even the most vexed, put fry in pot to buff and tack-free time, take out and dry in the air cool, grind to form 55 mesh powder;
(2) weigh step (1) obtain Herba Ephedrae, the Radix Paeoniae Alba, Rhizoma Zingiberis powder, mix homogeneously, grind to form 40 purposes
Powder, then will in powder add 15 times of weight distilled water, reflux, extract, 30-45 minute at 80 DEG C,
Then stand cooling, be filtrated to get supernatant;
(3) Herba Schizonepetae obtained, and Rhizoma Et Radix Notopterygii, Radix Platycodonis and Mus are processed by supernatant adds step (1)
Grass, boils 35 minutes, refluxes, then filter, obtain filtrate when boiling, and will add step (1) in filtrate
The Radix Glycyrrhizae powder obtained, stirring mixing, obtain pharmaceutical preparation.
Treatment embodiment 1
Grandson so-and-so, man, 35 years old, admission number 8073
Examination in hospital belongs to Intensive Care Therapy respiratory system infection.Generate heat 7 days, body temperature at about 38 DEG C, antiperspirant
Going out heat not understand, mouth is thirsty, headache, aversion to cold, micro-coughs, uncomfortable in chest, arthralgia, floating pulse taut band number, tongue fur
Bao Bai.Blood routine examination: leukocyte 10.4 × 10 ↑ 9/L, neutrophilia 0.67.Fluoroscopy of chest: hilus pulumonis is cloudy
Shadow increases deep, and non-activity sexually transmitted disease (STD) stove finds.
On the basis of carrying out conventional therapy, follow the doctor's advice, take the pharmaceutical preparation that the present invention provides, every day 3
Secondary, each take 55ml, after taking, drink the warm water of 150ml again, about 11 days, the state of an illness was clearly better.
Treatment embodiment 2
Guo so-and-so, female, 15 years old, recurrent cough 2 months, rise morning and cough very, abundant expectoration color is white, the most extremely
Flu 1 time, receives stagnant less, and pallor is simple and unadorned, night sweat, the difficultest yellow urine, white and greasy fur, soft and thready pulse.Once with many
Planting antibiotic therapy invalid, have a blood test Lactoferrin 112g/L, blood WBC 6300, N 0.54, L 0.46, rabat
Prompting: increased bronchovascular shadows, C3b 7.5%, CIC 2.8%.Diagnosis belongs to Intensive Care Therapy respiratory system infection.
On the basis of carrying out conventional therapy, follow the doctor's advice, take the pharmaceutical preparation that the present invention provides, every day 3
Secondary, each take 35ml, after taking, drink the warm water of 100ml again, about 15 days, the state of an illness was clearly better.
Check hemoglobin 125g/L, C3b 15.0%, CIC 2.5%.Rabat no abnormality seen.
The ultimate principle of the present invention and principal character and advantages of the present invention have more than been shown and described.The industry
Skilled person will appreciate that, the present invention is not restricted to the described embodiments, in above-described embodiment and description
The principle that the present invention is simply described described, without departing from the spirit and scope of the present invention, the present invention
Also having various changes and modifications, these changes and improvements both fall within scope of the claimed invention.This
The claimed scope of invention is defined by appending claims and equivalent thereof.
Claims (3)
1. the pharmaceutical preparation that can be used for Intensive Care Therapy respiratory system infection, it is characterised in that: include as follows
The component of weight portion:
Herba Ephedrae 7-9 part;
Radix Paeoniae Alba 5-7 part;
Rhizoma Zingiberis Recens 9-11 part;
Rhizoma Et Radix Notopterygii 5-7 part;
Radix Platycodonis 3-7 part;
Herba Schizonepetae 7-9 part;
Mus grass 3-5 part;
Radix Glycyrrhizae 13-15 part.
A kind of pharmaceutical preparation that can be used for Intensive Care Therapy respiratory system infection the most according to claim 1,
It is characterized in that: be prepared from by the component of following weight portion:
8 parts of Herba Ephedrae;
The Radix Paeoniae Alba 5 parts;
10 parts of Rhizoma Zingiberis Recens;
Rhizoma Et Radix Notopterygii 6 parts;
Radix Platycodonis 5 parts;
Herba Schizonepetae 8 parts;
Mus grass 5 parts;
14 parts of Radix Glycyrrhizae.
3. the method preparing pharmaceutical preparation as claimed in claim 1, it is characterised in that: include walking as follows
Rapid:
(1) Herba Ephedrae is sieved, remove impurity, be placed in mill groove, grind loosen into fiber velvet-like;By the Radix Paeoniae Alba
Being soaked in water to eighty per cant thoroughly, pull out, solarization is dried in the air, and profit to inside and outside humidity is uniform, section, then puts interior the stir-fry of pot
To coke yellow, spray clear water is a little, takes out, dries;Take fresh ginger, clean, mash, squeeze extracting juice,
Stand, divide the opaque taking precipitation, cold drying, obtain powder, then weigh;By Herba Schizonepetae cutting, put
In pot, micro-stir-fry at 70-90 DEG C, taking-up cools;Radix Glycyrrhizae section is added cooked Mel and a little boiled water, mixes
After even the most vexed, put fry in pot to buff and tack-free time, take out and dry in the air cool, grind to form 50-60 mesh powder;
(2) weigh step (1) obtain Herba Ephedrae, the Radix Paeoniae Alba, Rhizoma Zingiberis powder, mix homogeneously, grind to form 30-50
Purpose powder, then will add the distilled water of 10-15 times of weight, reflux, extract, at 80-85 DEG C in powder
30-45 minute, then stand cooling, be filtrated to get supernatant;
(3) Herba Schizonepetae obtained, and Rhizoma Et Radix Notopterygii, Radix Platycodonis and Mus are processed by supernatant adds step (1)
Grass, boils 20-35 minute, refluxes, then filter, obtain filtrate when boiling, and will add step (1) in filtrate
The Radix Glycyrrhizae powder obtained, stirring mixing, obtain pharmaceutical preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610521125.8A CN105944070A (en) | 2016-07-02 | 2016-07-02 | Medicine preparation for treating intensive care respiratory system infection and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610521125.8A CN105944070A (en) | 2016-07-02 | 2016-07-02 | Medicine preparation for treating intensive care respiratory system infection and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105944070A true CN105944070A (en) | 2016-09-21 |
Family
ID=56903399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610521125.8A Pending CN105944070A (en) | 2016-07-02 | 2016-07-02 | Medicine preparation for treating intensive care respiratory system infection and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105944070A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101979085A (en) * | 2010-11-05 | 2011-02-23 | 刘志稳 | Medicament for treating cough and asthma diseases |
CN101147788B (en) * | 2007-04-11 | 2011-05-11 | 秦庆吉 | Medicine for treating cold and upper respiratory tract infection and its lung inflammation |
CN101049424B (en) * | 2006-04-03 | 2012-01-18 | 湖南中达骛马制药有限责任公司 | Medication for treating infection in respiratory system |
CN103920080A (en) * | 2014-04-29 | 2014-07-16 | 周云飞 | Traditional Chinese medicine for treating acute and chronic bronchitis |
CN104435482A (en) * | 2014-10-09 | 2015-03-25 | 张伟 | Traditional Chinese medicine thick paste for preventing and treating respiratory tract infections and preparation method |
CN104548047A (en) * | 2015-01-29 | 2015-04-29 | 曹谦 | Spray for treating respiratory system diseases |
CN104826072A (en) * | 2015-05-25 | 2015-08-12 | 苗怡文 | Traditional Chinese medicine preparation for treating respiratory system infection and preparation method of traditional Chinese medicine preparation |
CN105288285A (en) * | 2015-11-12 | 2016-02-03 | 南京正亮医药科技有限公司 | Medicinal preparation for treating chronic bronchitis |
-
2016
- 2016-07-02 CN CN201610521125.8A patent/CN105944070A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101049424B (en) * | 2006-04-03 | 2012-01-18 | 湖南中达骛马制药有限责任公司 | Medication for treating infection in respiratory system |
CN101147788B (en) * | 2007-04-11 | 2011-05-11 | 秦庆吉 | Medicine for treating cold and upper respiratory tract infection and its lung inflammation |
CN101979085A (en) * | 2010-11-05 | 2011-02-23 | 刘志稳 | Medicament for treating cough and asthma diseases |
CN103920080A (en) * | 2014-04-29 | 2014-07-16 | 周云飞 | Traditional Chinese medicine for treating acute and chronic bronchitis |
CN104435482A (en) * | 2014-10-09 | 2015-03-25 | 张伟 | Traditional Chinese medicine thick paste for preventing and treating respiratory tract infections and preparation method |
CN104548047A (en) * | 2015-01-29 | 2015-04-29 | 曹谦 | Spray for treating respiratory system diseases |
CN104826072A (en) * | 2015-05-25 | 2015-08-12 | 苗怡文 | Traditional Chinese medicine preparation for treating respiratory system infection and preparation method of traditional Chinese medicine preparation |
CN105288285A (en) * | 2015-11-12 | 2016-02-03 | 南京正亮医药科技有限公司 | Medicinal preparation for treating chronic bronchitis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20230002351A (en) | Antibacterial and antiviral pharmaceutical composition and use thereof | |
CN1947754B (en) | Medicine for treating infantile asthma and its preparation method | |
US20150283072A1 (en) | Pre-operative beverages | |
CN104208245B (en) | Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method | |
CN114246925A (en) | Traditional Chinese medicine essential oil and application thereof | |
CN102258751A (en) | Traditional Chinese medicine composition mint for treating melancholia, dispelling melancholy and relieving depression | |
CN1251732C (en) | Chinese medicine for treating intrapulmonic infection and SARS | |
CN1785024A (en) | Bag-tea for treating pharyngitis and beneficial for throat | |
KR20040041865A (en) | herb medicine for remedying cold | |
CN106806758A (en) | A kind of Chinese medicine preparation for treating acne | |
CN105169339A (en) | Traditional Chinese medicine cleaning fluid for treating gynecologic inflammation | |
CN105381310A (en) | Traditional Chinese medicine preparation for treating phthisis and preparing method thereof | |
CN109549958A (en) | The composition and preparation method thereof for treating steroid dependent dermatitis | |
TW202330006A (en) | Composition for preventing, improving or alleviating symptoms relating to qi deficiency and/or blood deficiency | |
CN105944070A (en) | Medicine preparation for treating intensive care respiratory system infection and preparation method thereof | |
CN105343840A (en) | Traditional Chinese medicine for treating pneumonia for traditional Chinese medicine internal medicine department | |
CN106075229A (en) | A kind of Chinese medicinal composition preparation treating anemopyretic cold | |
CN1931229B (en) | Medicine for treating acute and chronic nasopharyngitis and its preparation process | |
CN105560984B (en) | Traditional Chinese medicine composition capable of boosting qi and invigorating spleen | |
CN105169149A (en) | Traditional Chinese medicine composition for treating pyrophlegm stasis accumulation type thyroid cancer, preparation method and application | |
CN103860976B (en) | A kind of pharmaceutical composition for the treatment of infant's dermatitis | |
CN104225344A (en) | Chinese herbal preparation for treating chronic nephropyelitis and preparation method thereof | |
Dhar et al. | Medicinal Plants of India | |
CN106074824A (en) | Enhancing immunity and the compositions of prophylactic treatment influenza, preparation technology and purposes | |
JP2001139487A (en) | Medicinal composition of nasal spray or nasal liquid medicine for pyrogenic common cold and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160921 |
|
RJ01 | Rejection of invention patent application after publication |